Overview

Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity

Status:
Completed

Trial end date:
2021-05-13

Target enrollment:

Participant gender:

Summary

A Phase 1 Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Midazolam
Rosuvastatin Calcium